Robert Taub

Robert Taub is a serial life sciences entrepreneur and the co-founder and Chairman of Nyxoah, a publicly traded medical technology company based in Belgium. Prior to establishing Nyxoah in 2009, he founded Omrix Biopharmaceuticals in 1995, scaling the biosurgical enterprise until its acquisition by Johnson & Johnson for approximately $438 million in 2008. Throughout his career, he has held numerous executive and board positions across the European biotechnology sector, including serving as Chairman of eTheRNA immunotherapies, a clinical-stage mRNA company. His academic credentials include a Master of Business Administration conferred by INSEAD in 1983 and a Bachelor of Arts in Languages from RUCA Antwerp University in 1969. Taub maintains a primary professional focus on advancing innovative medical devices and biopharmaceutical therapeutics from early-stage development through successful public market offerings and strategic corporate acquisitions.